Trial Profile
An Open-labelled, Controlled, Multicentre, Multinational, Extension Study Assessing Safety and Efficacy of the Human Insulin Analogue Insulin Aspart (X14) and Human Soluble Insulin as Meal Related Insulin in a Multiple Injection Regimen in Type 1 Diabetic Subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jan 2017
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin; Insulin suspension isophane
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 28 Apr 2015 New trial record